In Vitro Beating Heart Simulator for Minimally Invasive Heart Valve Therapy Research

Heart disease is the number one cause of death today with aortic valve stenosis (AVS) being a major contributor to the mortality rate¹. Because of the invasive nature of Aortic Valve Resection (AVR), the typical treatment for AVS, between 30–60% of patients affected by severe aortic stenosis cannot be treated surgically, usually due to age and advanced comorbidities. Qualifying individuals must undergo extensive rehabilitation and of those who qualify 4.3% to 25% do not survive the first year following the procedure^3,4.